← FDA Drug Approvals (Drugs@FDA)
GABAPENTIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GRANULES · Approved 2023-03-28
Drug application
- FDA Application #
ANDA217116- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GABAPENTIN
- Generic name
- GABAPENTIN
- Active ingredients
- GABAPENTIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- GRANULES
- Manufacturer
- Granules Pharmaceuticals Inc.
- First approval
- 2023-03-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown